Viewing Study NCT06596694


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-25 @ 11:48 PM
Study NCT ID: NCT06596694
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2024-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module